Skip to main content
. 2022 May 6;145(8):2671–2676. doi: 10.1093/brain/awac167

Figure 2.

Figure 2

Comparison of survival for ALS patients with <30 or ≥31 ATXN2 polyQ repeats. (A) All deceased patients. (B) All patients with censoring of those still alive.